logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Medicine (01276.HK) spent 9.7252 million yuan to repurchase 140,000 A shares on September 24th.

date
24/09/2025
The Zhitong Financial APP reported that Hengrui Medicine (01276.HK) announced that the company repurchased 140,000 A shares for a total of 9.7252 million yuan on September 24, 2025, at a repurchase price of 69.3-69.6 yuan per share.
Latest
2 m ago
Big Dragon Real Estate's stock is experiencing abnormal fluctuations, and the equity acquisition is still in the planning stage.
2 m ago
Big Dragon Real Estate: The holding subsidiary plans to acquire 60% equity of Beijing Chengzhu Real Estate Development Co., Ltd.
2 m ago
Worthbuying Technology: "Auntie Zhang" smart body products are being upgraded and developing a version of HarmonyOS application.
2 m ago
Nine Dragons Paper (09922.HK) issues 31.286 million stock purchase rights.
3 m ago
Yujing Co., Ltd. (002943.SZ) shareholder Que Shi Quan Li No.1 intends to reduce its holdings by no more than 4.28 million shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.